Shai Mulinari

Jan 5, 2025 | ebm.bmj.com | Piotr Ozieranski |Emily Rickard |Shai Mulinari |Lunds universitet

PolicyEthicsNew government legislation is necessary to ensure full transparency of industry payments in the UK’s healthcare. A first step should involve challenging the industry-driven discourse that allows company payment disclosures to be inconsequential for managing conflicts of interest.

Oct 12, 2024 | nature.com | Shai Mulinari

AbstractThe field of biological psychiatry faces a growing influx of digital biomarkers spanning self-report, social, behavioral, cognitive, and physiological indicators of various mental health conditions. However, the definition of “digital biomarker,” particularly the “bio-” component, remains unclear.

Jul 12, 2024 | xpresschronicle.com | Piotr Ozieranski |Shai Mulinari

Piotr Ozieranski, reader1, Shai Mulinari, associate professor2 The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK On 5 July 2024 the Prescription Medicines Code of Practice Authority (PMCPA), the drug industry’s self regulatory body, announced a landmark ruling.1 It publicly reprimanded Novo Nordisk, the pharmaceutical company with the “85.4% share of the global obesity care market,”2 for multiple...

Jul 12, 2024 | bmj.com | Piotr Ozieranski |Shai Mulinari

Opinion BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q1559 Cite this as: BMJ 2024;386:q1559 Piotr Ozieranski, reader1, Shai Mulinari, associate professor2 1Department of Social and Policy Sciences, University of Bath, Bath, UK 2Lund University, Lund, Sweden The latest Novo Nordisk revelations provide the strongest argument yet for a Sunshine Act for drug and medical device companies operating in the UK On 5 July 2024 the Prescription Medicines Code of Practice Authority (PMCPA), the drug...

Feb 14, 2024 | bmj.com | Hristio Boytchev |Shai Mulinari |Piotr Ozieranski

Hristio Boytchev, investigative reporter1, Shai Mulinari, associate professor2, Piotr Ozieranski, reader in sociology31The BMJ2Department of Sociology, Lund University, Sweden3University of Bath, Bath, UKhboytchev{at}bmj.comA major backlog has developed in handling complaints over drug companies’ marketing practices in the UK.